Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed May 13, 2015
Insider Transaction Report
Form 4
Logerfo Michael
Chief Legal Officer
Transactions
- Exercise/Conversion
Common Stock
2015-05-11$4.31/sh+2,759$11,891→ 56,482 total - Exercise/Conversion
Stock Option to Buy
2015-05-11−2,759→ 10,000 totalExercise: $4.31Exp: 2020-07-23→ Common Stock (2,759 underlying)
Holdings
- 1,000(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]Shares held by a member of Mr. Logerfo's immediate family sharing the same household. Mr. Logerfo disclaims beneficial ownership of such shares.
- [F2]Stock option granted on July 23, 2010 and vests 25% per year over four years.